RKLB vs YSS: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
RKLB is the larger of the two ($31.33B market cap): the incumbent the market prices for continued execution (650.39x forward earnings, beta 3.18). YSS is the smaller challenger ($502.28M), still expected to post a loss next year: more room to run, but more to prove. On the numbers, RKLB leads on both counts: faster expected revenue growth (37% vs 17%) and expected profits next year, which YSS does not have. The case for YSS rests on its own driver (Government space-architecture demand, now reshuffled): if you believe in that, YSS fits; if you believe in what the numbers show today, RKLB does.
RKLB vs YSS: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | RKLB | YSS | What it tells you |
|---|---|---|---|
| Market cap | $31.33B | $502.28M | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 650.39 | -3.51 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 8% of range | 1% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 5.13 | 0.46 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how RKLB and YSS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. RKLB and YSS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined RKLB and YSS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Rocket Lab (RKLB) do?
Rocket Lab (RKLB) is a space company that builds rockets and spacecraft and provides end-to-end space services. Its established business is the Electron, a small orbital launch vehicle that is one of the most frequently flown small rockets in the world, carrying satellites for commercial, government, and defense customers. Rocket Lab is developing Neutron, a larger, partly reusable medium-lift rocket intended to compete for bigger payloads and constellation deployments, directly targeting the market SpaceX dominates.
What does York Space Systems (YSS) do?
York Space Systems, Inc. (NYSE: YSS) is a vertically integrated space and defense prime headquartered in Greenwood Village, Colorado. Founded in 2012 and formerly known as Yellowstone Midco Holdings II, it designs, produces, integrates, and operates spacecraft and constellations built on standardized satellite platforms (S-CLASS, LX-CLASS, and M-CLASS). Its largest customer is the US Space Development Agency, where it has been a prime awardee across the Proliferated Warfighter Space Architecture (PWSA) tranches, and it is positioned into national-security programs tied to missile tracking and the Golden Dome initiative. The company went public in late January 2026 and has been acquiring suppliers, including propulsion maker Orbion Space Technology and solar-technology firm Solestial, to build out a more vertically integrated stack. In October 2026 it won two US Space Force task orders under the Space Data Network program and said it was extending its prime-integration work into geostationary orbit for space domain awareness missions.
RKLB vs YSS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- RKLB drivers: Neutron medium-lift rocket; Space Systems growth.
- YSS drivers: Government space-architecture demand, now reshuffled; Backlog conversion and revenue growth.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$222 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026 and about 29 million more shares in September tied to the Iridium deal, diluting holders. For YSS, york is not profitable, with a trailing net loss above ~$1.05B after a ~$807M third-quarter loss, trailing free cash flow of about negative ~$155M, and analysts expecting losses through 2027, so its valuation still depends on future growth and margin improvement that may not materialize.
RKLB or YSS: which should you pick?
If the story you believe is RKLB's (Neutron medium-lift rocket), RKLB is the more direct way to own it; if it is YSS's (Government space-architecture demand, now reshuffled), YSS is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the RKLB and YSS guides.
RKLB vs YSS: the full fundamentals
RKLB. Rocket Lab trades as a high-growth space name valued on its Space Systems revenue, backlog and the future option value of Neutron rather than current profits; forward P/E is not meaningful with expected EPS near zero. Even after falling from a 52-week high of $151 to about $46.54, the stock sits near 36x trailing sales, with Q4 2026 revenue guided to $270 million to $290 million and analysts' mean target near $93. Neutron test results and the Iridium closing matter more to valuation than near-term earnings.
YSS. York now trades at roughly 1.3 times trailing revenue and about 0.46 times book value, down from 1.9 times revenue in October and 6 to 8 times in mid-2026, with no positive earnings. Net cash of roughly $129M still covers about a quarter of the ~$504M market value, but the cushion has shrunk as losses and acquisitions consumed cash. Twelve analysts tracked by Yahoo carry a mean target near $9.75, with recent calls ranging from Jefferies' $6 to Canaccord's $9.
Headline figures (approximate, November 2026): RKLB shows revenue (ttm) ~$882 million, up ~73% year over year in Q3 2026, backlog ~$3.6 billion record (end Q3 2026), gross margin (ttm, gaap) ~36%, operating margin (ttm) ~-28%; YSS shows revenue (ttm) ~$398M (latest quarter ~$84M, down ~7% year over year), 2026 revenue outlook Guidance revised twice from the original ~$545M to $595M; consensus now ~$385M, net income (ttm) ~-$1.05B (net loss), including a ~$807M Q3 2026 loss, eps (q3 2026) -$0.33 vs ~-$0.20 expected (GAAP ~-$5.99 per share).
The bottom line: RKLB vs YSS
RKLB and YSS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined RKLB and YSS exposure against your real portfolio. It is not an investment adviser.
Wondering how RKLB or YSS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Rocket Lab
Ask Walnut's AI anything about RKLB and see how it fits what you own.
FAQ
What is the difference between RKLB and YSS?
+
Rocket Lab (RKLB) is a space company that builds rockets and spacecraft and provides end-to-end space services. York Space Systems, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is RKLB or YSS the better stock?
+
Neither is universally better. RKLB is the larger incumbent; YSS is the smaller challenger. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, RKLB or YSS?
+
A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both RKLB and YSS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of RKLB vs YSS?
+
RKLB: Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$222 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026 and about 29 million more shares in September tied to the Iridium deal, diluting holders. Neutron faces significant technical, schedule, and ramp risk: a tank ruptured during a hydrostatic test in January 2026 and the October 2026 dome issue pushed its first launch into 2027, and further slips would weigh on the stock, which trades largely on that future option. The pending Iridium acquisition, valued at roughly $8 billion, adds integration and execution risk and already cost about $21 million of transaction expenses in Q3. The launch market is dominated by SpaceX's scale and cost advantages, and competition in small launch and satellite components is intense. Mission failures, supply-chain issues, and lumpy, contract-driven revenue add volatility. At about 36x trailing sales even after a roughly 39% fall in 2026, Rocket Lab remains sensitive to sentiment, funding conditions, and milestone execution rather than steady fundamentals. YSS: York is not profitable, with a trailing net loss above ~$1.05B after a ~$807M third-quarter loss, trailing free cash flow of about negative ~$155M, and analysts expecting losses through 2027, so its valuation still depends on future growth and margin improvement that may not materialize. Jefferies, in downgrading the stock in November 2026, said it now sees a materially longer path to positive EBITDA. Customer concentration is significant, with the Space Development Agency a dominant buyer and a heavy mix of fixed-price contracts that can compress margins if costs run over, and the 2026 shift in SDA funding toward the Space Data Network Backbone exposes York to larger competitors. Management has revised 2026 revenue guidance twice, third-quarter revenue fell ~7% year over year, and backlog has declined, so further cuts are a live possibility. Cash fell to about $309M at September 30 from ~$534M earlier in the year, and further acquisitions such as the planned Outlook deal draw on the same pool. A federal securities class action alleges the IPO disclosures understated onboard software readiness and Department of Defense contract risks, which adds legal cost and uncertainty. As a company that only went public in January 2026, it has a short track record as a listed issuer and an extremely volatile share price (a 52-week range of roughly $3.46 to $44.54, with the low set in November 2026). Government budget shifts, program delays, and integration risk from recent acquisitions could all weigh on results.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell RKLB or YSS; figures are approximate and dated (as of November 2026). Verify current data before investing.